Henry Schein, Inc. $HSIC Shares Purchased by Russell Investments Group Ltd.

by · The Cerbat Gem

Russell Investments Group Ltd. raised its holdings in Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 15.8% in the 2nd quarter, HoldingsChannel reports. The fund owned 237,269 shares of the company’s stock after acquiring an additional 32,428 shares during the period. Russell Investments Group Ltd.’s holdings in Henry Schein were worth $17,333,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in the business. Vanguard Personalized Indexing Management LLC boosted its holdings in shares of Henry Schein by 3.5% during the second quarter. Vanguard Personalized Indexing Management LLC now owns 4,669 shares of the company’s stock worth $341,000 after purchasing an additional 157 shares during the last quarter. Equitable Trust Co. increased its stake in Henry Schein by 3.1% in the second quarter. Equitable Trust Co. now owns 5,317 shares of the company’s stock valued at $388,000 after purchasing an additional 158 shares during the last quarter. TD Asset Management Inc lifted its position in Henry Schein by 0.8% during the second quarter. TD Asset Management Inc now owns 22,016 shares of the company’s stock worth $1,608,000 after buying an additional 164 shares during the period. Radnor Capital Management LLC boosted its stake in Henry Schein by 1.6% in the 2nd quarter. Radnor Capital Management LLC now owns 11,415 shares of the company’s stock worth $834,000 after buying an additional 180 shares during the last quarter. Finally, Simon Quick Advisors LLC grew its holdings in Henry Schein by 5.5% in the 2nd quarter. Simon Quick Advisors LLC now owns 3,466 shares of the company’s stock valued at $253,000 after buying an additional 182 shares during the period. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have recently commented on HSIC shares. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Henry Schein in a research note on Friday. Evercore ISI upped their price target on shares of Henry Schein from $83.00 to $90.00 and gave the stock an “outperform” rating in a research report on Wednesday, November 5th. UBS Group decreased their price target on shares of Henry Schein from $75.00 to $70.00 and set a “neutral” rating on the stock in a report on Wednesday, August 6th. Morgan Stanley boosted their price objective on shares of Henry Schein from $55.00 to $58.00 and gave the company an “underweight” rating in a research note on Wednesday, November 5th. Finally, Barrington Research set a $79.00 target price on Henry Schein and gave the stock an “outperform” rating in a research report on Wednesday, November 5th. Five research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $76.08.

View Our Latest Analysis on HSIC

Henry Schein Price Performance

Henry Schein stock opened at $74.66 on Monday. The firm has a fifty day moving average of $67.74 and a 200-day moving average of $69.40. Henry Schein, Inc. has a 52-week low of $60.56 and a 52-week high of $82.49. The company has a quick ratio of 0.78, a current ratio of 1.41 and a debt-to-equity ratio of 0.51. The firm has a market capitalization of $8.79 billion, a P/E ratio of 24.08, a PEG ratio of 2.06 and a beta of 0.84.

Henry Schein (NASDAQ:HSIC – Get Free Report) last announced its quarterly earnings results on Tuesday, November 4th. The company reported $1.38 earnings per share for the quarter, topping analysts’ consensus estimates of $1.27 by $0.11. Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The firm had revenue of $3.34 billion during the quarter, compared to analysts’ expectations of $3.28 billion. Henry Schein has set its FY 2025 guidance at 4.880-4.960 EPS. As a group, analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current year.

Henry Schein Company Profile

(Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Read More

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC – Free Report).